May 2026
The global in vivo CAR-T therapy market size was evaluated at USD 650.00 million in 2025 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global in vivo cell reprogramming market is expanding as regenerative medicine advances toward direct in-body cell conversion for tissue repair and disease treatment.
June 2026
The global in vivo CRO market size is estimated to hit around USD 11.7 billion by 2035, increasing from USD 5.4 billion in 2025, with a CAGR of 8.11%.
June 2026
The global cell therapy manufacturing market size was valued at USD 5.55 billion in 2025 and is projected to hit around USD 21.02 billion by 2035 with a CAGR of 14.24%.
June 2026
The U.S. cell therapy manufacturing market size was evaluated at USD 1.71 billion in 2025 and is predicted to hit around USD 6.56 billion by 2035, growing at a CAGR of 14.39%.
June 2026
The global compounding chemotherapy market size was evaluated at USD 6.92 billion in 2025 and is predicted to surge around USD 13.36 billion by 2035, growing at a CAGR of 6.80%.
May 2026
The global advanced therapy medicinal products market size is projected to hit around USD 192.67 billion by 2035 increasing from USD 42.04 billion in 2025, with a CAGR of 16.44%.
May 2026
The global combination antibody therapy market size is estimated to hit around USD 700.59 billion by 2035 increasing from USD 241.03 billion in 2025, with a CAGR of 11.26%.
April 2026
The home infusion therapy market size was valued at USD 41.83 billion in 2025 and is projected to hit around USD 90.65 billion by 2035 with a CAGR of 8.04%.
April 2026
The global continuous renal replacement therapy market size is expected to increase to USD 3.77 billion by 2035 from USD 1.71 billion in 2025 at a CAGR of 8.23%.
April 2026
The global automation, digitization and robotics in cell and gene therapy manufacturing market size was evaluated at USD 950.00 million in 2025 and is predicted to hit around USD 5,275.10 million by 2035, growing at a CAGR of 18.70%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
March 2026
The global intensity modulated radiotherapy market size is estimated to hit around USD 5.10 billion by 2035 increasing from USD 2.71 billion in 2025, with a CAGR of xx%.
March 2026
The global radiotherapy monitoring devices market size is estimated to hit around USD 2.48 billion by 2035 increasing from USD 1.29 billion in 2025, with a CAGR of 6.74%.
February 2026
The global continuous renal replacement therapy consumables market size was evaluated at USD 920.17 million in 2025 and is predicted to hit around USD 2,069.01 million by 2035, growing at a CAGR of 8.44%.
February 2026
The global veterinary radiotherapy market size was evaluated at USD 3.59 billion in 2025 and is predicted to hit around USD 7.43 billion by 2035, growing at a CAGR of 7.56%.
December 2025
The global automated and closed cell therapy processing system market size is expected to hit around USD 14.46 billion by 2035 with a CAGR of 22.76%.
November 2025
The global alpha-1 antitrypsin deficiency augmentation therapy market size is estimated to hit around USD 2.96 billion by 2034 from USD 1.73 billion in 2025, at a CAGR of 6.14%.
August 2025
The intravenous (IV) hydration therapy market size reached USD 2.71 billion in 2024 and is projected to surpass around USD 5.84 billion by 2034, with a notable CAGR of 7.98%.
August 2025
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%.
July 2025
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 548.55 million in 2024, with a CAGR of 7.34%.
July 2025
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 11.60 billion in 2024, with a CAGR of 26.62%.
July 2025
The cell and gene therapy infrastructure market is expanding with scalable manufacturing, integrated delivery networks, and advanced clinical site readiness.
July 2025
The global nicotine replacement therapy market size is projected to surge around USD 353.86 billion by 2034 from USD 80.53 billion in 2024 with a CAGR of 15.95%.
July 2025
The global cold pain therapy market size was estimated at USD 2.22 billion in 2024 and is predicted to surpass around USD 3.64 billion by 2034 with a notable CAGR of 5.08%.
July 2025
The RNA therapy clinical trials market size was valued at USD 2.82 billion in 2024 and is expected to hit around USD 4.11 billion by 2034 with a CAGR of 3.84%.
July 2025
Explore the oncology combination therapy market, driven by rising cancer prevalence, improved treatment efficacy through drug combinations, and advancements in personalized medicine.
July 2025
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com